Aminoglycosides as Potential Pharmacogenetic Agents in the Treatment of Hailey–Hailey Disease
- 1 January 2006
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 126 (1) , 229-231
- https://doi.org/10.1038/sj.jid.5700031
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Effects of ultraviolet B irradiation, proinflammatory cytokines and raised extracellular calcium concentration on the expression of ATP2A2 and ATP2C1British Journal of Dermatology, 2005
- Hailey–Hailey disease as an orthodisease of PMR1 deficiency in Saccharomyces cerevisiaeFEBS Letters, 2005
- Expression of Hailey–Hailey Disease Mutations in YeastJournal of Investigative Dermatology, 2004
- Hailey–Hailey Disease and Calcium: Lessons from YeastJournal of Investigative Dermatology, 2004
- Calcium pump disorders of the skinAmerican Journal Of Medical Genetics Part C-Seminars In Medical Genetics, 2004
- Deficiency of polycystin‐2 reduces Ca2+channel activity and cell proliferation in ADPKD lymphoblastoid cellsThe FASEB Journal, 2004
- Readthrough of dystrophin stop codon mutations induced by aminoglycosidesAnnals of Neurology, 2004
- Functional Expression in Yeast of the Human Secretory Pathway Ca2+, Mn2+-ATPase Defective in Hailey-Hailey DiseaseJournal of Biological Chemistry, 2002
- The Golgi Apparatus Plays a Significant Role in the Maintenance of Ca2+ Homeostasis in the vps33ΔVacuolar Biogenesis Mutant of Saccharomyces cerevisiaeJournal of Biological Chemistry, 1999
- Hailey–Hailey disease: the clinical features, response to treatment and prognosisBritish Journal of Dermatology, 1992